AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 63 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 6.78 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $6,000 | -66.7% | 105,668 | 0.0% | 0.00% | – |
Q2 2022 | $18,000 | -93.0% | 105,668 | -80.7% | 0.00% | – |
Q1 2022 | $257,000 | -17.4% | 546,394 | 0.0% | 0.00% | – |
Q4 2021 | $311,000 | -64.8% | 546,394 | +2.6% | 0.00% | – |
Q3 2021 | $884,000 | +9.5% | 532,527 | +10.3% | 0.00% | – |
Q2 2021 | $807,000 | +350.8% | 482,955 | +357.0% | 0.00% | – |
Q1 2021 | $179,000 | -3.2% | 105,668 | -9.4% | 0.00% | – |
Q4 2020 | $185,000 | +270.0% | 116,591 | +123.9% | 0.00% | – |
Q3 2020 | $50,000 | +138.1% | 52,067 | +24.3% | 0.00% | – |
Q3 2019 | $21,000 | +31.2% | 41,876 | 0.0% | 0.00% | – |
Q2 2019 | $16,000 | -86.3% | 41,876 | -79.8% | 0.00% | – |
Q1 2019 | $117,000 | +41.0% | 207,728 | -0.5% | 0.00% | – |
Q4 2018 | $83,000 | -21.7% | 208,876 | 0.0% | 0.00% | – |
Q3 2018 | $106,000 | -76.2% | 208,876 | +3.1% | 0.00% | – |
Q2 2018 | $446,000 | +153.4% | 202,590 | +290.2% | 0.00% | – |
Q1 2018 | $176,000 | +14.3% | 51,926 | +37.0% | 0.00% | – |
Q4 2017 | $154,000 | +516.0% | 37,916 | -8.0% | 0.00% | – |
Q3 2017 | $25,000 | +25.0% | 41,201 | +8.7% | 0.00% | – |
Q2 2017 | $20,000 | -81.7% | 37,916 | -71.9% | 0.00% | – |
Q1 2017 | $109,000 | -10.7% | 135,142 | -0.2% | 0.00% | – |
Q4 2016 | $122,000 | +18.4% | 135,376 | -2.5% | 0.00% | – |
Q3 2016 | $103,000 | -45.5% | 138,910 | -5.0% | 0.00% | – |
Q2 2016 | $189,000 | +32.2% | 146,186 | +128.9% | 0.00% | – |
Q1 2016 | $143,000 | -16.9% | 63,856 | +30.2% | 0.00% | – |
Q4 2015 | $172,000 | +26.5% | 49,062 | +3.9% | 0.00% | – |
Q3 2015 | $136,000 | +19.3% | 47,220 | -1.8% | 0.00% | – |
Q2 2015 | $114,000 | -94.5% | 48,096 | -82.7% | 0.00% | -100.0% |
Q1 2015 | $2,090,000 | +200.7% | 277,582 | +37.1% | 0.00% | – |
Q4 2014 | $695,000 | -2.8% | 202,497 | +0.0% | 0.00% | – |
Q3 2014 | $715,000 | -79.2% | 202,398 | -50.9% | 0.00% | – |
Q2 2014 | $3,440,000 | +221.2% | 411,900 | +144.4% | 0.00% | – |
Q1 2014 | $1,071,000 | -0.7% | 168,504 | +11.3% | 0.00% | – |
Q4 2013 | $1,079,000 | -31.6% | 151,377 | -28.1% | 0.00% | – |
Q3 2013 | $1,578,000 | +169.3% | 210,472 | +107.0% | 0.00% | – |
Q2 2013 | $586,000 | – | 101,672 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,595,484 | $5,710,000 | 4.85% |
Cypress Capital Management LLC (WY) | 321,725 | $708,000 | 0.74% |
Noven Financial Group, Inc. | 103,964 | $229,000 | 0.12% |
Transform Wealth, LLC | 205,481 | $452,000 | 0.08% |
Cutter & CO Brokerage, Inc. | 50,000 | $110,000 | 0.04% |
TRUSTCORE FINANCIAL SERVICES, LLC | 44,500 | $98,000 | 0.04% |
GHP Investment Advisors, Inc. | 100,000 | $220,000 | 0.03% |
BRIGHTON JONES LLC | 85,555 | $188,000 | 0.02% |
Valeo Financial Advisors, LLC | 330,000 | $155,000 | 0.02% |
TRUSTCORE FINANCIAL SERVICES, LLC | 27,348 | $60,000 | 0.02% |